Skip to Content
Merck
  • Aplasia cutis congenita after exposure to methimazole: a causal relationship?

Aplasia cutis congenita after exposure to methimazole: a causal relationship?

The British journal of dermatology (1995-12-01)
T Vogt, W Stolz, M Landthaler
ABSTRACT

We report a child with scalp aplasia cutis congenita, whose mother was treated with methimazole during pregnancy. The relationship between antithyroid drug administration during pregnancy and the occurrence of scalp defects is discussed, and the pertinent literature is reviewed.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Mercapto-1-methylimidazole, ≥99%
Thiamazole, European Pharmacopoeia (EP) Reference Standard
Supelco
Methimazole, analytical standard
USP
Methimazole, United States Pharmacopeia (USP) Reference Standard
Supelco
Methimazole, VETRANAL®, analytical standard